Validation of the Generalized Anxiety Disorder Screener (GAD-7) in Cypriot Pregnant and Postpartum Women

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2022 Nov 15

PMID 36380278

Authors

Paris Vogazianos

Emma Motrico

Sara Dominguez-Salas

Andri Christoforou

Eleni Hadjigeorgiou

Affiliations

Soon will be listed here.

Abstract

Background: Anxiety is increasingly acknowledged as a common mental health issue during the perinatal period. Its prevalence as well as the associated adverse effects constitute screening imperative. This study evaluates the psychometric properties and underlying factor structures of a Greek version of GAD-7 among pregnant and postpartum women (up to 6 months) in Cyprus.

Methods: This study was conducted from June to December 2020. A total of 457 Cypriot women in the perinatal period (222 pregnant and 235 postpartum) were surveyed. The assessment included anxiety (GAD-7) and depression (EPDS), and psychosocial factors related with anxiety. The internal consistency and factor structure of GAD-7 were evaluated using reliability coefficients, Cronbach's Alpha and McDonald's Omega, and factor analysis, both Exploratory as well as Confirmatory.

Results: GAD-7 demonstrated good internal consistency (α = 0.907; Ω = 0.909). Horn's parallel analysis indicated a single factor as the most appropriate. CFA using the standard ML method indicated a good model fit, χ = 21.207, p = 0.096; CFI = 0.999; SRMR = 0.027. More studies are needed to determinate the cut-off point and the maximisation of the scale's sensitivity and specificity in pregnant and postpartum Greek Cypriot women.

Conclusions: GAD-7 is a valid and reliable measure and healthcare professionals should utilize GAD-7 as a standard instrument for the screening of anxiety symptoms in pregnant and postpartum Greek Cypriot women.

Citing Articles

Psychobiotics Ameliorate Depression and Anxiety Status in Surgical Oncology Patients: Results from the Study.

Tzikos G, Chamalidou E, Christopoulou D, Apostolopoulou A, Gkarmiri S, Pertsikapa M Nutrients. 2025; 17(5).

PMID: 40077722 PMC: 11901992. DOI: 10.3390/nu17050857.

Psychometric properties of the generalized anxiety disorder questionnaire (GAD-7) in a polish postpartum women sample.

Lutkiewicz K, Bieleninik L, Jurek P, Bidzan M BMC Public Health. 2024; 24(1):2706.

PMID: 39367428 PMC: 11451098. DOI: 10.1186/s12889-024-20194-5.

A cross-country study on the impact of governmental responses to the COVID-19 pandemic on perinatal mental health.

Mesquita A, Costa R, Bina R, Cadarso-Suarez C, Gude F, Diaz-Louzao C Sci Rep. 2023; 13(1):2805.

PMID: 36797263 PMC: 9933810. DOI: 10.1038/s41598-023-29300-w.

References

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

Li C . Confirmatory factor analysis with ordinal data: Comparing robust maximum likelihood and diagonally weighted least squares. Behav Res Methods. 2015; 48(3):936-49. DOI: 10.3758/s13428-015-0619-7. View

Fairbrother N, Corbyn B, Thordarson D, Ma A, Surm D . Screening for perinatal anxiety disorders: Room to grow. J Affect Disord. 2019; 250:363-370. DOI: 10.1016/j.jad.2019.03.052. View

Grigoriadis S, Graves L, Peer M, Mamisashvili L, Tomlinson G, Vigod S . Maternal Anxiety During Pregnancy and the Association With Adverse Perinatal Outcomes: Systematic Review and Meta-Analysis. J Clin Psychiatry. 2018; 79(5). DOI: 10.4088/JCP.17r12011. View

Tomfohr-Madsen L, Racine N, Giesbrecht G, Lebel C, Madigan S . Depression and anxiety in pregnancy during COVID-19: A rapid review and meta-analysis. Psychiatry Res. 2021; 300:113912. PMC: 9755112. DOI: 10.1016/j.psychres.2021.113912. View

Nath S, Ryan E, Trevillion K, Bick D, Demilew J, Milgrom J . Prevalence and identification of anxiety disorders in pregnancy: the diagnostic accuracy of the two-item Generalised Anxiety Disorder scale (GAD-2). BMJ Open. 2018; 8(9):e023766. PMC: 6129087. DOI: 10.1136/bmjopen-2018-023766. View

Field T . Prenatal anxiety effects: A review. Infant Behav Dev. 2017; 49:120-128. DOI: 10.1016/j.infbeh.2017.08.008. View

Farre-Sender B, Torres A, Gelabert E, Andres S, Roca A, Lasheras G . Mother-infant bonding in the postpartum period: assessment of the impact of pre-delivery factors in a clinical sample. Arch Womens Ment Health. 2017; 21(3):287-297. DOI: 10.1007/s00737-017-0785-y. View

Viswasam K, Eslick G, Starcevic V . Prevalence, onset and course of anxiety disorders during pregnancy: A systematic review and meta analysis. J Affect Disord. 2019; 255:27-40. DOI: 10.1016/j.jad.2019.05.016. View

10.

. The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression. Obstet Gynecol. 2015; 125(5):1268-1271. DOI: 10.1097/01.AOG.0000465192.34779.dc. View

11.

Fawcett E, Fairbrother N, Cox M, White I, Fawcett J . The Prevalence of Anxiety Disorders During Pregnancy and the Postpartum Period: A Multivariate Bayesian Meta-Analysis. J Clin Psychiatry. 2019; 80(4). PMC: 6839961. DOI: 10.4088/JCP.18r12527. View

12.

Ding X, Wu Y, Xu S, Zhu R, Jia X, Zhang S . Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies. J Affect Disord. 2014; 159:103-10. DOI: 10.1016/j.jad.2014.02.027. View

13.

Grigoriadis S, Graves L, Peer M, Mamisashvili L, Tomlinson G, Vigod S . A systematic review and meta-analysis of the effects of antenatal anxiety on postpartum outcomes. Arch Womens Ment Health. 2018; 22(5):543-556. DOI: 10.1007/s00737-018-0930-2. View

14.

Robertson E, Grace S, Wallington T, Stewart D . Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004; 26(4):289-95. DOI: 10.1016/j.genhosppsych.2004.02.006. View

15.

Zhong Q, Gelaye B, Zaslavsky A, Fann J, Rondon M, Sanchez S . Diagnostic Validity of the Generalized Anxiety Disorder - 7 (GAD-7) among Pregnant Women. PLoS One. 2015; 10(4):e0125096. PMC: 4411061. DOI: 10.1371/journal.pone.0125096. View

16.

Gong Y, Zhou H, Zhang Y, Zhu X, Wang X, Shen B . Validation of the 7-item Generalized Anxiety Disorder scale (GAD-7) as a screening tool for anxiety among pregnant Chinese women. J Affect Disord. 2021; 282:98-103. DOI: 10.1016/j.jad.2020.12.129. View

17.

Dennis C, Falah-Hassani K, Shiri R . Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis. Br J Psychiatry. 2017; 210(5):315-323. DOI: 10.1192/bjp.bp.116.187179. View

18.

Sinesi A, Maxwell M, OCarroll R, Cheyne H . Anxiety scales used in pregnancy: systematic review. BJPsych Open. 2019; 5(1):e5. PMC: 6343118. DOI: 10.1192/bjo.2018.75. View

19.

Simpson W, Glazer M, Michalski N, Steiner M, Frey B . Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period. Can J Psychiatry. 2014; 59(8):434-40. PMC: 4143300. DOI: 10.1177/070674371405900806. View

20.

Byrne B . Factor analytic models: viewing the structure of an assessment instrument from three perspectives. J Pers Assess. 2005; 85(1):17-32. DOI: 10.1207/s15327752jpa8501_02. View